Pharmacology News

The demand for self-managed medication abortions increased substantially after the abortion law S.B. 8 went into effect in Texas, according to findings published in JAMA Network Open.

During his State of the Union address, President Joe Biden announced the launch of a new test-to-treat initiative, in which people who test positive for SARS-CoV-2 at a pharmacy can receive antivirals “on the spot at no cost.”

The Endocrine Society condemned a new Texas directive that defines gender-affirming care in children, such as reassignment surgeries and hormone treatment, as “child abuse.” It was the top story in endocrinology last week.

Excess daily intake of sodium from soluble or effervescent acetaminophen may increase risk for CVD and all-cause death, regardless of baseline hypertension status, according to research published in the European Heart Journal.

A sublingual film form of the selective alpha-2a-adrenergic receptor agonist dexmedetomidine significantly reduced mild to moderate agitation in patients with bipolar disorder, a phase 3 randomized trial showed.

Patients on long-term opioid treatment struggle to receive continuous, high-quality care, two experts wrote in a research letter published in the New England Journal of Medicine.

The U.S. Preventive Services Task Force recommended statins for the primary prevention of CVD in patients aged 40 to 75 years with at least one CVD risk factor and 10% or greater 10-year risk for CVD.

Convalescent plasma with high neutralizing antibodies produced a strong and rapid viral clearance when administered to patients hospitalized with COVID-19, according to recent data.

A multilevel program that provided support and resources to rural primary care practices was associated with an increase in buprenorphine prescriptions, data show.

Researchers reported substantial variability in information on sex-based differences in drug safety and efficacy across trial publications and FDA sources for medications that were approved in 2019 and 2020.